SC Labs is First to Create a Hemp Testing Panel that Covers a Range of Contaminants at a National Level


Ryan Allway

June 14th, 2021

News


Company aims to fill the void of national hemp testing requirements to reassure companies and consumers that products are safe

 

(Santa Cruz, CA, June 14, 2021) – – SC Laboratories, Inc. (SC Labs) today announced that the company has received ISO (International Organization for Standardization) accreditation for a comprehensive hemp/CBD testing panel that combines the regulatory requirements of all states that publish hemp testing rules. At present, there are no federally-required testing regulations for hemp and each state has its own set of requirements, making it difficult for consumers to navigate the safety of products and for companies to qualify products beyond individual state standards. SC Labs now offers a suite of tests that target state-specific requirements for multiple states and a Comprehensive Test Panel that targets a complete list of contaminants and active constituents at the lowest action limits as required by each state.

 

According to SC Labs CEO Jeff Gray, “As an industry, we’ve been advocating for national, standardized, and transparent testing regulations for years now. The government has been slow to respond so we decided it was time to act. The test we’ve created meets or exceeds the requirements of most states and that will give consumers greater peace of mind. No one else can say that right now.”

 

SC Labs is currently licensed in California, Oregon, Texas, and Colorado (pending) so cannabis operators in those states will benefit from this comprehensive panel with assurance that products meet all state requirements. Depending on compliance regulations in other states, producers may use this test for quality assurance purposes prior to testing at a state-licensed laboratory for each state as required.

 

“Although these expanded offerings are targeted for hemp, they are also relevant to our cannabis clients who want to go beyond compliance regulations,” said Gray. “As more companies aim to expand products nationally, we saw a need for testing at a universal level so we poured our efforts into the development of a test that would meet those needs. It’s paid off because we have several national brands that are implementing the test panel as the quality assurance standard for their line of hemp-derived CBD products.”

 

This new comprehensive testing panel covers a range of cannabinoids, pesticides, microbiological contaminants, mycotoxins, heavy metals, and residual solvents, combining each individual state’s requirements, thus meeting the highest regulatory bar. With the lack of parity between states, the test is a harmonization of regulations that also takes into account emerging contaminants. The panel can also be customized to meet test methods or quality standards from organizations like United States Pharmacopeia (USP), American Herbal Products Association (AHPA), and the American Herbal Pharmacopoeia (AHP).

 

About SC Labs

SC Labs offers comprehensive solutions for cannabis and hemp testing. Our analytical data empowers thousands of clients to make informed decisions about product safety and consistency. Accredited to ISO 17025 in California and by ORELAP in Oregon, and with hemp testing licenses covering multiple states, we offer essential tools to carefully cultivate and distribute cannabis and hemp products. SC Labs is headquartered in Santa Cruz, California. For more information, visit www.sclabs.com.

 

###

 

The test meets the hemp testing standards of states with requirements in terms of action limits and analytes for contaminants including pesticides, heavy metals, microbiology, mycotoxins, residual solvents, and water activity. This does not apply to inhalable hemp sample types.

Media contact:
Beth Graham
KMACannabis.com
Beth@KipMorrison.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading